Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Alexandra Allard-Coutu, Victoria Dobson, Erika Schmitz, Hely Shah & Carolyn Nessim. (2023) The Evolution of the Sentinel Node Biopsy in Melanoma. Life 13:2, pages 489.
Crossref
Crossref
Julian Scheper, Laura S. Hildebrand, Eva-Maria Faulhaber, Lisa Deloch, Udo S. Gaipl, Julia Symank, Rainer Fietkau, Luitpold V. Distel, Markus Hecht & Tina Jost. (2022) Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts. Strahlentherapie und Onkologie.
Crossref
Crossref
Philip Sutera, Matthew P. Deek, Kim Van der Eecken, Alexander W. Wyatt, Amar U. Kishan, Jason K. Molitoris, Matthew J. Ferris, M. Minhaj Siddiqui, Zaker Rana, Mark V. Mishra, Young Kwok, Elai Davicioni, Daniel E. Spratt, Piet Ost, Felix Y. Feng & Phuoc T. Tran. (2022) Genomic biomarkers to guide precision radiotherapy in prostate cancer. The Prostate 82:S1.
Crossref
Crossref
Eun Kyung Choi. (2022) Genetic variations affecting response of radiotherapy. Journal of Genetic Medicine 19:1, pages 1-6.
Crossref
Crossref
Sepideh Nezhadi & Farid Abedin Dorkoosh. (2021) Co-delivery systems: hope for clinical application?. Drug Delivery and Translational Research 12:6, pages 1339-1354.
Crossref
Crossref
Camil Ciprian Mireștean, Roxana Irina Iancu & Dragoș Petru Teodor Iancu. (2022) Education in Radiation Oncology—Current Challenges and Difficulties. International Journal of Environmental Research and Public Health 19:7, pages 3772.
Crossref
Crossref
Zeqing Chen, Shijie Huang & Muqing Liu. (2021) The review of the light parameters and mechanisms of Photobiomodulation on melanoma cells. Photodermatology, Photoimmunology & Photomedicine 38:1, pages 3-11.
Crossref
Crossref
Jessica A Scarborough & Jacob G Scott. (2022) Translation of Precision Medicine Research Into Biomarker-Informed Care in Radiation Oncology. Seminars in Radiation Oncology 32:1, pages 42-53.
Crossref
Crossref
Shoaib Shoaib, Gurmanpreet Kaur, Khurram Yusuf & Nabiha Yusuf. 2022. Herbal Medicines. Herbal Medicines
307
328
.
Yi Ge, Xuanlin Che, Xin Gao, Shuang Zhao & Juan Su. (2021) Combination of radiotherapy and targeted therapy for melanoma brain metastases: a systematic review. Melanoma Research 31:5, pages 413-420.
Crossref
Crossref
Rania Hamdy, Bahgat Fayed, Ahmed Mostafa, Noura M. Abo Shama, Sara Hussein Mahmoud, Chetan Hasmukh Mehta, Yogendra Nayak & Sameh S. M. Soliman. (2021) Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity. International Journal of Molecular Sciences 22:16, pages 9057.
Crossref
Crossref
Stephanie McKenna & Lucía García-Gutiérrez. (2021) Resistance to Targeted Therapy and RASSF1A Loss in Melanoma: What Are We Missing?. International Journal of Molecular Sciences 22:10, pages 5115.
Crossref
Crossref
Surachet Imlimthan, You Cheng Khng, Outi Keinänen, Wenzhong Zhang, Anu J. Airaksinen, Mauri A. Kostiainen, Brian M. Zeglis, Hélder A. Santos & Mirkka Sarparanta. (2021) A Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma. Small 17:18.
Crossref
Crossref
Daniel A. Pomeranz Krummel, Tahseen H. Nasti, Benjamin Izar, Robert H. Press, Maxwell Xu, Lindsey Lowder, Laura Kallay, Manali Rupji, Havi Rosen, Jing Su, Walter Curran, Jeffrey Olson, Brent Weinberg, Matthew Schniederjan, Stewart Neill, David Lawson, Jeanne Kowalski, Mohammad K. Khan & Soma Sengupta. (2020) Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases. International Journal of Radiation Oncology*Biology*Physics 108:1, pages 157-163.
Crossref
Crossref
Fausto Petrelli, Agostina De Stefani, Francesca Trevisan, Chiara Parati, Alessandro Inno, Barbara Merelli, Michele Ghidini, Lorenza Bruschieri, Elisabetta Vitali, Mary Cabiddu, Karen Borgonovo, Mara Ghilardi, Sandro Barni & Antonio Ghidini. (2019) Combination of radiotherapy and immunotherapy for brain metastases: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 144, pages 102830.
Crossref
Crossref
Mohammad Krayem, Malak Sabbah, Ahmad Najem, An Wouters, Filip Lardon, Stephane Simon, François Sales, Fabrice Journe, Ahmad Awada, Ghanem E. Ghanem & Dirk Van Gestel. (2019) The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers 11:8, pages 1093.
Crossref
Crossref
Emmanuelle Couty, Alexis Vallard, Sandrine Sotton, Sarra Ouni, Max-Adrien Garcia, Sophie Espenel, Chloe Rancoule, Majed Ben Mrad, Anne-Catherine Biron, Jean-Luc Perrot, Julien Langrand-Escure & Nicolas Magné. (2019) Safety assessment of anticancer drugs in association with radiotherapy in metastatic malignant melanoma: a real-life report. Cancer Chemotherapy and Pharmacology 83:5, pages 881-892.
Crossref
Crossref
Susanne Stera, Panagiotis Balermpas, Oliver Blanck, Robert Wolff, Stefan Wurster, Rene Baumann, Marcella Szücs, Britta Loutfi-Krauss, Maria-Lisa Wilhelm, Volker Seifert, Dirk Rades, Claus Rödel, Jürgen Dunst, Guido Hildebrandt, Andreas Arnold, Markus Meissner & Katharina C. Kähler. (2019) Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma. Melanoma Research 29:2, pages 187-195.
Crossref
Crossref
Panagiotis Mastorakos, Zhiyuan Xu, James Yu, Judith Hess, Jack Qian, Ajay Chatrath, Davis G Taylor, Douglas Kondziolka, Ronald Warnick, Veronica Chiang & Jason Sheehan. (2019) BRAF V600 Mutation and BRAF Kinase Inhibitors in Conjunction With Stereotactic Radiosurgery for Intracranial Melanoma Metastases: A Multicenter Retrospective Study. Neurosurgery 84:4, pages 868-880.
Crossref
Crossref
Jaymin JhaveriMudit Chowdhary, Xinyan ZhangRobert H. PressJeffrey M. SwitchenkoMatthew J. FerrisTiffany M. MorganJustin RoperAnees DhabaanEric ElderBree R. EatonJeffrey J. Olson, Walter J. CurranHui-Kuo G. ShuIan R. CrockerKirtesh R. Patel. (2019) Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases. Journal of Neurosurgery 130:3, pages 797-803.
Crossref
Crossref
B. Shannan, J. Matschke, H. Chauvistré, F. Vogel, D. Klein, F. Meier, D. Westphal, J. Bruns, R. Rauschenberg, J. Utikal, A. Forschner, C. Berking, P. Terheyden, E. Dabrowski, R. Gutzmer, D. Rafei-Shamsabadi, F. Meiss, L. Heinzerling, L. Zimmer, Elisabeth Livingstone, Renáta Váraljai, A. Hoewner, S. Horn, J. Klode, M. Stuschke, B. Scheffler, A. Marchetto, G. Sannino, T.G.P. Grünewald, D. Schadendorf, V. Jendrossek & A. Roesch. (2019) Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma. European Journal of Cancer 109, pages 137-153.
Crossref
Crossref
Ana-Maria Buga, Anca Docea, Carmen Albu, Ramona Malin, Daciana Branisteanu, Gabriel Ianosi, Simona Ianosi, Andrei Iordache & Daniela Calina. (2019) Molecular and cellular stratagem of brain metastases associated with melanoma (Review). Oncology Letters.
Crossref
Crossref
Mudit Chowdhary, Jeffrey M. Switchenko, Robert H. Press, Jaymin Jhaveri, Zachary S. Buchwald, Philip A. Blumenfeld, Gaurav Marwaha, Aidnag Diaz, Dian Wang, Ross A. Abrams, Jeffrey J. Olson, Hui-Kuo G. Shu, Walter J. Curran & Kirtesh R. Patel. (2018) Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery. Journal of Neuro-Oncology 139:3, pages 689-697.
Crossref
Crossref
R. J. Rodenburg, P. E. Hanssens, V. K. Y. Ho & L. V. Beerepoot. (2018) Validation of the Chowdhury overall survival score in patients with melanoma brain metastasis treated with Gamma Knife Radiosurgery. Journal of Neuro-Oncology 138:2, pages 391-399.
Crossref
Crossref
Anna M. Rose, Utsav K. Radia, Rong Luo, Helen Kalirai, Channa N. Jayasena, Philip Luthert, Sarah E. Coupland & Geoffrey E. Rose. (2018) Multiple primary malignancies and prolonged survival in a patient with widespread metastatic cutaneous melanoma. Melanoma Research 28:2, pages 163-166.
Crossref
Crossref
Charlee Nardin, Christine Mateus, Mathieu Texier, Emilie Lanoy, Salima Hibat-Allah, Samy Ammari, Caroline Robert & Frederic Dhermain. (2018) Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases. Melanoma Research 28:2, pages 111-119.
Crossref
Crossref
Mudit Chowdhary, Derick Okwan-Duodu, Jeffrey M. Switchenko, Robert H. Press, Jaymin Jhaveri, Zachary S. Buchwald, Jim Zhong, Bhavana V. Chapman, Ranjit S. Bindra, Joseph N. Contessa, Henry S. Park, James B. Yu, Roy H. Decker, Jeffrey J. Olson, Nelson M. Oyesiku, Ross A. Abrams, Hui-Kuo G. Shu, Walter J. CurranJr.Jr., Ian R. Crocker & Kirtesh R. Patel. (2017) Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery. Journal of Neuro-Oncology 136:2, pages 289-298.
Crossref
Crossref
Rodica Di Lorenzo & Manmeet S. Ahluwalia. (2017) Targeted therapy of brain metastases: latest evidence and clinical implications. Therapeutic Advances in Medical Oncology 9:12, pages 781-796.
Crossref
Crossref
Paul W. Sperduto, Wen Jiang, Paul D. Brown, Steve Braunstein, Penny Sneed, Daniel A. Wattson, Helen A. Shih, Ananta Bangdiwala, Ryan Shanley, Natalie A. Lockney, Kathryn Beal, Emil Lou, Thomas Amatruda, William A. Sperduto, John P. Kirkpatrick, Norman Yeh, Laurie E. Gaspar, Jason K. Molitoris, Laura Masucci, David Roberge, James Yu, Veronica Chiang & Minesh Mehta. (2017) The Prognostic Value of BRAF , C-KIT , and NRAS Mutations in Melanoma Patients With Brain Metastases. International Journal of Radiation Oncology*Biology*Physics 98:5, pages 1069-1077.
Crossref
Crossref